Physiological levels of nitrate support anoxic growth by denitrification of Pseudomonas aeruginosa at growth rates reported in cystic fibrosis lungs and sputum

Frontiers in Microbiology

Volumn 5, Issue OCT, 2014, Pages

  Line, Laura ^a,b   Alhede, Morten ^a,b   Kolpen, Mette ^a,b   Kühl, Michael ^c,d,e   Ciofu, Oana ^b   Bjarnsholt, Thomas ^a,b   Moser, Claus ^a   Toyofuku, Masanori ^f   Nomura, Nobuhiko ^f   Høiby, Niels ^a,b   Jensen, Peter Østrup ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^e NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^f UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Cystic fibrosis; Denitrification; Growth; Pseudomonas aeruginosa

Indexed keywords

GROWTH PROMOTOR; NITRATE; NITRITE REDUCTASE; NITROUS OXIDE;

ANOXIA; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; CYSTIC FIBROSIS; DENITRIFICATION; FLOW CYTOMETRY; FLUORESCENCE; GENE EXPRESSION; GROWTH RATE; LUNG CYSTIC FIBROSIS; NONHUMAN; PLASMID; PROTEIN SYNTHESIS; PSEUDOMONAS AERUGINOSA; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SPUTUM;

PSEUDOMONAS AERUGINOSA;

EID: 84910038563     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2014.00554     Document Type: Article

References (69)

1. Aanaes K, Rickelt LF, Johansen HK, von Buchwald C, Pressler T, Høiby N, Jensen PØ. (2011) Decreased mucosal oxygen tension in the maxillary sinuses in patients with cystic fibrosis. J. Cyst.Fibros. 10(2): 114-20l
2. Alvarez-Ortega C & Harwood CS. (2007) Responses of Pseudomonas aeruginosa to low oxygen indicate that growth in the cystic fibrosis lung is by aerobic respiration. Molecular Microbiol. 65(1): 153-165
3. Andersen K, Kjær T, Revsbech NP. (2001) An oxygen insentitive microsensor for nitrous oxide. Sensors & Actuators B: Chemical 81:42-48
4. Arai H. (2011) Regulation and function of versatile aerobic and anaerobic respiratory metabolism in Psuedomonas aeruginosa. Front. Microbiol. 2:103
5. Beckmann C, Brittnacher M, Ernst R, Mayer-Hamblett N, Miller SI, Burns JL. (2005) Use of phage display to identify potential Pseudomonas aeruginosa gene products relevant to early cystic fibrosis airway infections. Infect. Immun. 73:444-452.
6. Bjarnsholt T, Jensen PØ, Fiandaca MJ, Pedersen J, Hansen CR, Andersen CB, Pressler T, Givskov M, Høiby N. (2009) Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr. Pulmonol. 44:547-558
7. Chen J, Strous M. (2013) Denitrification and aerobic respiration, hybrid electron transport chain and co-evolution. Biochem. Biophys. Acta. 1827:136-144
8. Choi KH, Kumar A, Schweizer HP. (2005) A 10-min method for preparation of highly electrocompetent Pseudomonas aeruginosa cells: Application for DNA fragment transfer between chromosomes and plasmid transformation. J. Microbiol. Met. 64(3):391-397
9. Craggs TD. (2009) Green fluorescent protein: structure, folding and chromophore maturation. Chem. Soc. Rev. 38:2865-2875
10. Cramer N, Klockgether J, Wrasman K, Schmidt M, Davenport CF, Tümmler B. (2011) Microevolution of the major common Pseudomonas aeruginosa clones C and PA14 in cystic fibrosis lungs. Environ. Microbiol. 13:1690-1704
11. Dwyer DJ, Belenky PA, Yang JH, MacDonald IC, Martell JD, Takahashi N, Chan CTY, Lobritz MA, Braff D, Schwarz EG, Ye JD, Pati M, Vercruysse M, Ralifo PS, Allison KR, Khalil AS, Ting AY, Walker GC, Collins JJ. (2014). Antibiotics induce redox-related physiological alterations as part of their lethality. PNAS. 11 1(20):E2100-9. doi: 10.1073/pnas. 1401876111
12. Eschbach M, Schreiber K, Trunk K, Buer J, Jahn D, Schobert M. (2004) Long-term anaerobic survival of the opportunistic pathogen Pseudomonas aeruginosa via pyruvate fermentation. J. Bacteriol. 186(14):4596-4604
13. Fang H, Toyofuku M, Kiyokawa T, Ichihashi A, Tateda K, Nomura N. (2013) The impact of anaerobiosis on strain-dependent phenotypic variations in Pseudomonas aeruginosa. Biosci. Biotechnol. Biochem. 77(8): 1747-52
14. Filiatrault MJ, Picardo KF, Ngai H, Passador L, Iglewski BH. (2006) Identification of Pseudomonas aeruginosa Genes Involved in Virulence and Anaerobic Growth. Infect. Immun. 174(7):4237 -4245
15. Gaston B, Ratjen F, Vaughan JW, Malhotra NR, Canady RG, Snyder AH, Hunt JF, Gaertig S, Goldberg JB. (2002). Nitrogen redox balance in the cystic fibrosis airway: effects of antipseudomonal therapy. Am. J. Respir. Crit. Care. Med. 165(3):387-90
16. Glasser NR, Kern SE, Newman DK. (2014) Phenazine redox cycling enhances anaerobic survival in Pseudomonas aeruginosa by facilitating generation of ATP and a proton-motive force. Molecular Microbiol. 92(2): 3 99-412
17. Govan JR, Deretic V. (1996) Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60(3):539-574
18. Grasemann H, Ioannidis I, Tomkiewicz RP, de Groot H, Rubin B, Ratjen F. (1998) Nitric oxide metabolites in cystic fibrosis lung disease. Arch. Dis. Child. 78:49-53
19. Härtig E, Zumft WG. (1999) Kinetics ofnirS expression (cytochrome cd1 nitrite reductase) in Pseudomonas stutzeri during the transition from aerobic respiration to denitrification: evidence for a denitrification-specific nitrate- and nitrite-responsive regulatory system. J Bacteriol. 181(1): 161-6
20. Hentzer M, Eberl L, Givskov M. (2005) Transcriptome analysis of Pseudomonas aeruginosa biofilm development: anaerobic respiration and iron limitation. Biofilms. 2(1):37-61
21. Hoboth C, Hoffmann R, Eichner A, Henke C, Schmoldt S, Imhof A, Heesemann J, Hogardt M. (2009) Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis. J. Infect. Dis. 200:118-130
22. Hoffman LR, Kulasekara HD, Emerson J, Houston LS, Burns JL, Ramsey BW, Miller SI. (2009) Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression. J. Cyst. Fibros. 8(1):66-70
23. Hoffman LR, Richardson AR, Houston LS, Kulasekara HD, Martens-Habbena W, Klausen M, Burns JL, Stahl DA, Hassett DJ, Fang FC, Miller SI. (2010) Nutrient availability as a mechanism for selection of antibiotic tolerant Pseudomonas aeruginosa within the CF airway. PLoS. Pathog. 6(1):e1000712. doi: 10.1371/journal.ppat. 1000712
24. Holloway BW, Krishnapillai V, Morgan AF. (1979) Chromosomal genetics of Pseudomonas. Microbiol. Rev. 43:73-102
25. Høiby N, Ciofu O, Bjarnsholt T. (2004) Pseudomonas aeruginosa Biofilms in Cystic Fibrosis. Future Microbiol. 5(11): 1663-1674
26. Høiby N. (2006) P. aeruginosa in Cystic Fibrosis Patients Resists Host Defenses, Antibiotics. Microbe. 1(12):571-577
27. Høiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. (2010) Antibiotic resistance of bacterial biofilms. Int JAntimicrob Agents. 35(4):322-332
28. Jones KL, Hegab AH, Hillman BC, Simpson KL, Jinkins PA, Grisham MB, Owens MW, Sato E, Robbins RA. (2000) Elevation of nitrotyrosine and nitrate concentrations in cystic fibrosis sputum. Pediatr. Pulmonol. 30:79-85.
29. 2 concentration. Soil. Biol. Biochem. 36:687-699
30. Koch C, Høiby N. (2000) Diagnosis and treatment of cystic fibrosis. Respiration. 67(3):239-247
31. Kolpen M, Hansen CR, Bjarnsholt T, Moser C, Christensen LD, Gennip Mv, Ciofu O, Mandsberg L, Kharazmi A, Döring G, Givskov M, Høiby N, Jensen PØ. (2010). Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis. THORAX. 65(1):57-62
32. Kolpen M, Bjarnsholt T, Moser C, Hansen C.R., Richelt L, Kühl M, Hempel C, Pressler T, Høiby N, Jensen P. Ø. (2014a) Nitric oxide production by polymorphonuclear leukocytes in infected cystic fibrosis sputum. Clin Exp Immunol. 177(1):310-319
33. Kolpen M, Kühl M, Bjarnsholt T, Moser C, Hansen C.R, Liengaard L, Kharazmi A, Pressler T, Høiby N, Jensen PØ. (2014b) Nitrous Oxide Production in Sputum from Cystic FibrosisPatients with Chronic Pseudomonas aeruginosa Lung Infection. PLoS One. 9(1):e84353. doi: 10.1371/journal.pone.0084353
34. Kolpen M, Kragh KN, Bjarnsholt T, Line L, Hansen CR, Dalbøge CS, Hansen N, Kühl M, Høiby N, Jensen PØ. (2014c) Denitrification by Cystic Fibrosis Pathogens -Stenotrophomonas maltophilia is dormant in sputum. Int. J. Med. Microbiol. DOI: 10.1016/j.ijmm.2014.07.002
35. Kolpen M, Bjarnsholt T, Moser C, Hansen C.R., Richelt L, Kühl M, Hempel C, Pressler T, Høiby N, Jensen P. Ø. (2014a) Nitric oxide production by polymorphonuclear leukocytes in infected cystic fibrosis sputum. Clin Exp Immunol. 177(1):310-319
36. Kragh KN, Alhede M, Jensen PØ, Moser C, Scheike T, Jacobsen CS, Seier S, Eickhardt S, Trøstrup H, Chri Stoffer son L, Hougen HP, Rickelt LF, Kühl M, Høiby N, Bjarnsholt T. (2014) Polymorphonuclear Leukocytes Restrict the Growth of Pseudomonas aeruginosa in the Lungs of Cystic Fibrosis Patients. Infect. Immun. pii: IAI.01969-14 (IN PRESS)
37. Lee B, Schjerling CK, Kirkby N, Hoffmann N, Borup R, Molin S, Høiby N, Ciofu O. (2011) Mucoid P. aeruginosa isolates maintain the biofilm formation capacity and the gene expression profiles during the chronic lung infection of CF patients. APMIS. 119:263-274;
38. Lee KM, Go J, Yoon MY, Park Y, Kim SC, Yong DE, Yoon SS. (2012) Vitamin B12-ediated restoration of defective anaerobic growth leads to reduced biofilm formation in Pseudomonas aeruginosa. Infect. Immun. 80(5): 1639-49
39. Maseda H, Sawada I, Saito K, Uchiyama H, Nakae T, Nomura N. (2004) Enhancement of the mexAB-oprM efflux pump expression by a quorum-sensing autoinducer and its cancellation by a regulator, MexT, of the mexEF-oprN efflux pump operon in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 48:1320-1328
40. McCaughey G, Gilpin DF, Schneiders T, Hoffman LR, McKevitt M, Elborn JS, Tunney MM. (2013) Fosfomycin and tobramycin in combination downregulate nitrate eductase genes NarG and narH, resulting in increased activity against Pseudomonas aeruginosa under anaerobic conditions. Antimicrob. Agents. Chemother. 57(11):5406-5414
41. Meyer RL, Allen DE, Schmidt S. (2008) Nitrification and denitrification as sources of sediment nitrous oxide production: A microsensor approach. Mar. Chem. 110:68-76
42. Oberhardt MA, Goldberg JB, Hogardt M, Papin JA. (2010) Metabolic network analysis of Pseudomonas aeruginosa during chronic cystic fibrosis lung infection. J. Bacteriol. 192(20):5534-5548
43. Palmer KL, Brown SA, Whiteley M. (2007) Membrane-bound nitrate reductase is required for anaerobic growth in cystic fibrosis sputum. J. Bacteriol. 189(12):4449-4455
44. Quinn RA, Lim YW, Maughan H, Conrad D, Rohwer F, Whiteson KL. (2014) Biogeochemical forces shape the composition and physiology of polymicrobial communities in the cystic fibrosis lung. mBio 5(2):e00956-13. doi:10.1128/mBio.00956-13
45. Ratjen F, Döring G. (2003) Cystic Fibrosis. Lancet. 361(9358):681-9.
46. Rowe SM, Miller S, Sorscher EJ. (2005) Mechanisms of Disease: Cystic Fibrosis. N. Engl. J.Med. 352:1992-2001
47. Savli H, Karadenizili A, Kolayli F, Gundes S, Ozbeck U and Vahaboglu H. (2003) Expression stability of six housekeeping genes: a proposal for resistance gene quantification studies of Pseudomonas aeruginosa by real-time quantitative RT-PCR. J. Med. Microbiol. 52:403-408
48. Schobert M, Jahn D. (2010) Anaerobic physiology of Pseudomonas aeruginosa in the cystic fibrosis lung. Int. J. Med. Microbiol. 300:549-556
49. Schreiber K, Krieger R, Benkert B, Eschbach M, Arai H, Schobert M, Jahn D. (2007) The Anaerobic Regulatory Network Required for Pseudomonas aeruginosa Nitrate Respiration. J.Bacteriol. 189(11):4310-4314
50. Simon R, O'Connell M, Labes M, Pühler A. (1986). Plasmid vector for the genetic analysis and manipulation of rhizobia and other gram-negative bacteria. Methods Enzymol. 118:640-659
51. Son MS, Matthews WJ Jr, Kang Y, Nguyen DT, Hoang TT. (2007) In vivo evidence of Pseudomonas aeruginosa nutrient acquisition and pathogenesis in the lungs of cystic fibrosis patients. Infect. Immun. 75(11):5313-5324
52. Strack RL, Strongin DE, Mets L, Glick BS, Keenan RJ. (2010) Chromophore Formation in DsRed Occurs by a Branched Pathway. J. Am. Chem. Soc. 132:8496-8505
53. Toyofuku M, Nomura M, Fujii t, Takaya N, Maseda H, Sawada I, Nakajima T, Uchiyama H. (2007) Quorum sensing regulates denitrification in Pseudomonas aeruginosa PAO1. J. Bacteriol. 189(13):4969-4972
54. Toyofuku M, Zhou S, Sawada I, Takaya N, Uchimyama H, Nomura N. (2013). Membrane vesicle formation is associated with pyocin production under denitrifying conditions in Pseudomonas aeruginosa PAO1. Environ. Microbiol. 16(9):2927-38. doi: 10.1111/1462-2920.12260
55. Trunk K, Benkert B, Quäck N, Münch R, Scheer M, Garbe J, Jänsch L, Trost M, Wehland J, Buer J, Jahn M, Schobert M, Jahn D. (2010) Anaerobic adaptation in Pseudomonas aeruginosa: definition of the Anr and Dnr regulons. Environ. Microbiol. 12(6): 1719-1733
56. Tunney MM, Field TR, Moriarty TF, Patrick S, Döring G, Muhlebach MS, Wolfgang MC, Boucher R, Gilpin DF, McDowell A, Elborn JS. (2008) Detection of anaerobic bacteria inhigh numbers in sputum from patients with cystic fibrosis. Am. J. Resp. Crit. Care Med. 177(9):995-1001
57. Van Alst NE, Wellington M, Clark VL, Haidaris CG, Iglewski BH. (2009) Nitrite Reductase NirS Is Required for Type III Secretion System Expression and Virulence in the Human Monocyte Cell Line THP-1 by Pseudomonas aeruginosa. Infect. Immun. 77(10):4446-4454
58. Vander Wauven C, Pierard A, Kley-Raymann M, Haas D. (1984) Pseudomonas aeruginosa mutants affected in anaerobic growth on arginine: evidence for a four-gene cluster encoding the arginine deiminase pathway. J. Bacteriol. 160:928-934
59. Walters MC, Roe F, Bugnicourt A, Franklin MJ, Stewart PS. (2003) Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob. Agents Chemother. 47(1):317-23
60. West JB. Respiratory Physiology: The Essentials, 6th ed. Baltimore: Lippincott Williams & Wilkins; 2000.
61. Weiss RF, Price BA. (1980) Nitrous oxide solubility in water and seawater. Marine Chemistry 8:347-359.
62. Widdel F. (2007) Theory and Measurement of Bacterial Growth. University Bremen, pp. 11.
63. Winsor GL, Lam DK, Fleming L, Lo R, Whiteside MD, Yu NY, Hancock RE, Brinkman FS. (2011) Pseudomonas Genome Database: improved comparative analysis and population genomics capability for Pseudomonas genomes. Nucleic Acids Res. 39(Database issue):D596-600.
64. Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer KC, Birrer P, Bellon G, Berger J, Weiss T, Botzenhart K, Yankaskas JR, Randell S, Boucher RC, Döring G. (2002)Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Invest. 109:317-325.
65. Yang L, Haagensen JAJ, Jelsbak L, Johansen HK, Sternberg C, Høiby N, Molin S. (2008) In Situ Growth Rates and Biofilm Development of Pseudomonas aeruginosa Populations in Chronic Lung Infections. J. Bacteriol. 190:2767-2776
66. Yoon SS, Hennigan RF, Hilliard GM, Ochsner UA, Parvatiyar K, Kamani MC, Allen HL, DeKievit TR, Gardner PR, Schwab U, Rowe JJ, Iglewski BH, McDermott TR, Mason RP, Wozniak DJ, Hancock RE, Parsek MR, Noah TL, Boucher RC, Hassett DJ. (2002) Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Developmental Cell. 3:593-603.
67. Zhang C, Xing XH, Lou K. (2005) Rapid detection of a gfp-marked Enterobacter aerogenes under anaerobic conditions by aerobic fluorescence recovery. FEMSMicrobiol. Lett. 249:211-218
68. Zumft WG. (1997) Cell biology and molecular basis of denitrification. Microbiol. Mol. Biol. Rev. 61:533-616.
69. Zumft WG. (2005) Nitric oxide reductases of prokaryotes with emphasis on the respiratory, heme-copper oxidase type. J. Inorg. Biochem. 99:194-215